Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in Adults: Clinical Outcome and Complications
Status: Recruiting
Location: See all (2) locations...
Study Type: Observational
SUMMARY
To collect baseline and outcome data relating to all bone marrow, peripheral blood, cord blood hematopoietic stem cell transplants and therapies related to hematopoietic stem cell transplantation performed in Queen Mary Hospital.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Adult patients aged 18 years or older who received allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Locations
Other Locations
Hong Kong Special Administrative Region
Department of Medicine, Queen Mary Hospital
RECRUITING
Hong Kong
Queen Mary Hospital, Hong Kong
RECRUITING
Hong Kong
Contact Information
Primary
Harry HS Gill, MBBS, MD, FRCP, FRCPath
gillhsh@hku.hk
+852 22555859
Time Frame
Start Date: 2024-12
Estimated Completion Date: 2030-12
Participants
Target number of participants: 1000
Treatments
All patients receiving allogeneic HSCT at Queen Mary Hospital, Hong Kong
Related Therapeutic Areas
Sponsors
Leads: The University of Hong Kong